The Fly

The Fly is a top digital publisher that delivers real-time financial news. Our goal is straightforward yet challenging: to cover and clarify the news that affects publicly traded companies. With our unique live streaming subscription service, we provide critical information that influences stock movements. If you're curious about what's causing a stock to rise or fall, The Fly is your go-to source. Our team of financial market specialists knows that news affecting stock prices can come from any source, at any time. We diligently sift through a wide range of company news, from traditional outlets to innovative platforms, ensuring that we only present short, impactful stories that matter. Our experts monitor various sources, including analyst reports, company announcements, SEC filings, newspapers, blogs, social media, and trading desk insights. The Fly acts as your guide through the often intricate landscape of stock news. We have offices located in Summit, New Jersey, Bayside, New York, and Buenos Aires, Argentina.

International, Trade/B2B

English

Financial/Market news

Outlet metrics

Domain Authority

Ranking

Global

#192934

United States

#55614

Finance/Investing

#532

Traffic sources

Monthly visitors

Articles

Home - The Fly

2 days ago | thefly.com | Gary Deduke |Sam Martinelli |Jessica de Sa-Mota

ODD Managers: $65.255.5M Shares Proprietary deal commentary available to members only. Sign up or login for access. Create FREE Account Proprietary deal commentary available to members only. Sign up or login for access. UTI Managers: $33.301.93M Shares Proprietary deal commentary available to members only. Sign up or login for access. Create FREE Account Proprietary deal commentary available to members only. Sign up or login for access.
Home - The Fly

3 days ago | thefly.com | Gary Deduke |Sam Martinelli |Jessica de Sa-Mota |Brianna West

OMSE Managers: $9.003.7M Shares Proprietary deal commentary available to members only. Sign up or login for access. Create FREE Account Proprietary deal commentary available to members only. Sign up or login for access. CTMX AEE Managers: $94.005.55M Shares Proprietary deal commentary available to members only. Sign up or login for access. Create FREE Account Proprietary deal commentary available to members only. Sign up or login for access. SGI
Home - The Fly

1 week ago | thefly.com | Gary Deduke |Sam Martinelli |Jessica de Sa-Mota

Proprietary deal commentary available to members only. Sign up or login for access. NDAQ AHL Managers: $30.0013.25M Shares Proprietary deal commentary available to members only. Sign up or login for access. Create FREE Account Proprietary deal commentary available to members only. Sign up or login for access. AII Managers: $16.006.875M Shares Proprietary deal commentary available to members only. Sign up or login for access.
Home - The Fly

1 week ago | thefly.com | Sam Martinelli |Andrew Perez |Jessica de Sa-Mota

We use cookies to improve user experience, and analyze website traffic. For these reasons, we may share your site usage data with our analytics partners. By clicking "Accept Cookies" you consent to store on your device all the technologies described in our
Home - The Fly

1 week ago | thefly.com | Sam Martinelli |Jessica de Sa-Mota |Brianna West

We use cookies to improve user experience, and analyze website traffic. For these reasons, we may share your site usage data with our analytics partners. By clicking "Accept Cookies" you consent to store on your device all the technologies described in our
Home - The Fly

1 month ago | thefly.com | Gary Deduke |Sam Martinelli |Jessica de Sa-Mota

LGPS Managers: $5.002M Shares Proprietary deal commentary available to members only. Sign up or login for access. Create FREE Account Proprietary deal commentary available to members only. Sign up or login for access. AEP Managers: $102.0019608 Shares Proprietary deal commentary available to members only. Sign up or login for access. Create FREE Account Proprietary deal commentary available to members only. Sign up or login for access.
Home - The Fly

1 month ago | thefly.com | Jessica de Sa-Mota |Andrew Perez |Gary Deduke

We use cookies to improve user experience, and analyze website traffic. For these reasons, we may share your site usage data with our analytics partners. By clicking "Accept Cookies" you consent to store on your device all the technologies described in our
Trump Trade: White House refining tariff strategy for April 2 measures FMCC;FNMA;HYMTF;TSLA;RKLB;SPCE;BA;LMT;ATGE;APEI;LOPE;LINC;STRA

1 month ago | thefly.com | Jessica de Sa-Mota

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly: TARIFF STRATEGY: The White House is refining its tariff strategy for the measures set to take effect on April 2, likely excluding industry-specific tariffs while imposing reciprocal duties on select nations that make up the majority of U.S. foreign trade, The Wall Street Journal's Gavin Bade,...
What You Missed On Wall Street On Friday LUV;FDX;NKE;JNJ;BA;ALK;DAL;JBLU;UAL;SAVE;AAL;HLF;FDS;ADBE;AZO;DNB;COIN;WMG;FUBO;PARA;PARAA;RIO;TSLA;OUST;ALNY;SMCI;MNSO;NUE;MU;KLTR;CCL;LEN;NIO

1 month ago | thefly.com | Sam Martinelli

Five top five lists with the news and calls moving stocks, powered by The Fly. The major indexes ended the session higher, continuing a two-day rally that interrupted a month-long selloff amid trade policy uncertainty, recession worries, and a downturn in megacap tech stocks.
Biotech Alert: Searches spiking for these stocks today LYEL;IMVT;ATXI;JAGX;GNPX;MRVI;CNSP;TNXP;MLYS;RGNX;CAPR;PHAT;INO;ARCT;SANA;ONCO

1 month ago | thefly.com | Sam Martinelli

Stay ahead of biotech stocks seeing a surge in interest from retail and financial professional investors with this exclusive recap from The FlyThese names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include:Pipeline and key clinical candidates for these companies:Lyell is a clinical-stage company advancing a pipeline of next-generation CAR T-cell therapies for patients with hematologic malignancies and solid tumors.